Emcure Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	92,035	78,960	66,583	59,858	58,554
Other Revenue	126.64	-	-	-	-
Revenue	92,162	78,960	66,583	59,858	58,554
Revenue Growth (YoY)	16.72%	18.59%	11.23%	2.23%	16.33%
Cost of Revenue	36,571	32,225	25,357	23,185	22,864
Gross Profit	55,591	46,735	41,225	36,673	35,690
Selling, General & Admin	15,522	17,264	15,577	13,069	11,805
Other Operating Expenses	22,057	14,782	13,351	11,597	10,562
Operating Expenses	41,729	35,887	32,052	27,459	24,835
Operating Income	13,862	10,847	9,173	9,214	10,855
Interest Expense	-1,437	-1,302	-2,032	-1,849	-1,470
Interest & Investment Income	-	90.44	207.59	118.34	101.97
Currency Exchange Gain (Loss)	1,188	437.59	203.77	190.15	367.78
Other Non Operating Income (Expenses)	-	-314.36	-205.93	-137.55	-124.92
EBT Excluding Unusual Items	13,614	9,759	7,346	7,536	9,730
Gain (Loss) on Sale of Investments	-	58.04	25.32	1.21	-
Gain (Loss) on Sale of Assets	-	-	-	-3.33	-4.08
Other Unusual Items	-742.13	-103.78	-99.31	-61.46	-
Pretax Income	12,871	9,713	7,272	7,472	9,725
Income Tax Expense	3,459	2,639	1,997	1,854	2,700
Earnings From Continuing Operations	9,413	7,075	5,276	5,618	7,026
Net Income to Company	9,413	7,075	5,276	5,618	7,026
Minority Interest in Earnings	-169.08	-261.35	-293.92	-298.26	-403.56
Net Income	9,244	6,813	4,982	5,320	6,622
Net Income to Common	9,244	6,813	4,982	5,320	6,622
Net Income Growth	35.67%	36.76%	-6.36%	-19.66%	68.86%
Shares Outstanding (Basic)	190	187	181	181	181
Shares Outstanding (Diluted)	190	187	181	181	181
Shares Change (YoY)	1.33%	3.41%	0.01%	-	-
EPS (Basic)	48.77	36.43	27.54	29.42	36.62
EPS (Diluted)	48.77	36.43	27.54	29.42	36.62
EPS Growth	33.88%	32.27%	-6.38%	-19.66%	68.90%
Free Cash Flow	5,830	6,299	8,215	3,563	3,900
Free Cash Flow Per Share	30.76	33.68	45.42	19.70	21.57
Dividend Per Share	-	3.000	-	2.000	3.000
Dividend Growth	-	-	-	-33.33%	200.00%
Gross Margin	60.32%	59.19%	61.92%	61.27%	60.95%
Operating Margin	15.04%	13.74%	13.78%	15.39%	18.54%
Profit Margin	10.03%	8.63%	7.48%	8.89%	11.31%
Free Cash Flow Margin	6.33%	7.98%	12.34%	5.95%	6.66%
EBITDA	18,013	14,121	11,805	11,446	12,911
EBITDA Margin	19.55%	17.88%	17.73%	19.12%	22.05%
D&A For EBITDA	4,150	3,274	2,632	2,232	2,057
EBIT	13,862	10,847	9,173	9,214	10,855
EBIT Margin	15.04%	13.74%	13.78%	15.39%	18.54%
Effective Tax Rate	26.87%	27.17%	27.45%	24.81%	27.76%
Revenue as Reported	92,162	79,633	67,021	60,317	59,189
Advertising Expenses	-	2,734	2,585	1,828	1,633

Source: S&P Global Market Intelligence. Standard template. Financial Sources.